SCHEMBL6510484

SCHEMBL6510484

O=C(O)c1cc([N+](=O)[O-])ccc1S

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
TDP1 Q9NUW8 2/20 0.59
CYP3A4 P08684 1/20 0.59
ALOX15 P16050 1/20 0.59
MAPT P10636 3/20 0.58
TP53 P04637 2/20 0.54
HTT P42858 2/20 0.54
CTSV O60911 2/20 0.54
CTSL P07711 2/20 0.54
KMT2A Q03164 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
MEN1 O00255 1/20 0.50
GAA P10253 1/20 0.50
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
MYC P01106 1/20 0.48
MAX P61244 1/20 0.48
AKR1C4 P17516 1/20 0.47
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7221805 0.85 ALDH1A1 (0.64) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL30868088 0.84 KMT2A (0.60) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL3480944 0.83 ALDH1A1 (0.47) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL260006 0.82 ALDH1A1 (0.70) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL8177530 0.81 ALDH1A1 (0.59) ALDH1A1TDP1CYP3A4ALOX15MAPT
Hydrochloric Acid SCHEMBL10694658 0.81 ALDH1A1 (0.68) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL6342762 0.81 ALDH1A1 (0.62) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL679262 0.81 ALDH1A1 (0.62) ALDH1A1TDP1CYP3A4ALOX15MAPT
Hydrochloric Acid SCHEMBL10694666 0.81 ALDH1A1 (0.68) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL11351093 0.81 ALDH1A1 (0.68) ALDH1A1TDP1CYP3A4ALOX15MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3859804-B1 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS CANON KK (JP) 2024-08-07 EP claimed
US-5272077-A Method for preparing a covalent conjugate of an oligonucleotide and an enzyme EASTMAN KODAK COMPANY (US) 1993-12-21 US claimed
EP-0417841-A2 An oligonucleotide-enzyme conjugate and a method for its preparation EASTMAN KODAK COMPANY (US) 1991-03-20 EP claimed
US-12245446-B2 Semiconductor device having quantum dots, display device, imaging system, and moving body CANON KABUSHIKI KAISHA (JP) 2025-03-04 US disclosed
EP-3859804-B1 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS CANON KK (JP) 2024-08-07 EP disclosed
CN-115975030-A anti-CD 39 antibody-drug conjugates and uses thereof 杭州邦顺制药有限公司 2023-04-18 CN disclosed
CN-113694964-B Bionic laccase system based on polysaccharide/dopamine composite membrane as well as preparation method and application of bionic laccase system 中国科学院化学研究所 2022-08-02 CN disclosed
CN-113694964-A Bionic laccase system based on polysaccharide/dopamine composite membrane as well as preparation method and application thereof 中国科学院化学研究所 2021-11-26 CN disclosed
CN-113285024-A Semiconductor device having quantum dots, display device, imaging system, and moving object 佳能株式会社 2021-08-20 CN disclosed
US-20210242416-A1 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS, DISPLAY DEVICE, IMAGING SYSTEM, AND MOVING BODY CANON KABUSHIKI KAISHA (JP) 2021-08-05 US disclosed
EP-3859804-A2 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS CANON KABUSHIKI KAISHA (JP) 2021-08-04 EP disclosed
US-5254469-A Oligonucleotide-enzyme conjugate that can be used as a probe in hybridization assays and polymerase chain reaction procedures EASTMAN KODAK COMPANY (US) 1993-10-19 US disclosed
EP-0551916-A2 Process for stabilisation of proteins Roche Diagnostics GmbH (DE) 1993-07-21 EP disclosed
US-5082780-A OLIGONUCLEOTIDE-ENZYME CONJUGATE THAT CAN BE USED AS A PROBE IN HYBRIDIZATION ASSAYS AND POLYMERASE CHAIN REACTION PROCEDURES EASTMAN KODAK COMPANY (US) 1992-01-21 US disclosed
EP-0417841-A2 An oligonucleotide-enzyme conjugate and a method for its preparation EASTMAN KODAK COMPANY (US) 1991-03-20 EP disclosed
EP-0026000-B1 SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Takeda Chemical Industries, Ltd. (JP) 1983-05-11 EP disclosed
US-4362740-A ANTICOAGULANTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1982-12-07 US disclosed
US-4272506-A BINDING A LABELED MEMBER OF A SPECIFIC BINDING PAIR TO A MERCAPTO-ACTIVATED SUPPORT THROUGH CLEAVABLE DISULFIDE LINKAGES; IMMUNOASSAY; ACCURACY SYVA COMPANY (US) 1981-06-09 US disclosed
EP-0026000-A1 Spiro compounds, process for their preparation and pharmaceutical compositions containing them Takeda Chemical Industries, Ltd. (JP) 1981-04-01 EP disclosed
US-3954994-A Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents PFIZER INC. (US) 1976-05-04 US disclosed